Merck & Co.
Search results
Organon, here for her health. We are a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established brands across a wide array of conditions and diseases.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine , contraception , psychiatry , hormone replacement therapy (HRT), and anesthesia .
We show up every day to turn the promise of Organon into a reality. We’re called to create what has been missing in women’s healthcare and are dedicated to improving everyday health for women around the world.
We aim to improve health care economies and treatment access by providing high-quality biosimilar medicines to health care systems, providers, and patients. Learn more about Organon Biosimilars. With insights from our customers, we work to understand the needs of all stakeholders and seek to exceed their expectations.
Mar 11, 2020 · Fueled by its leading contraceptives and fertility businesses, Organon will invest in innovations that support the distinct health care needs of women today.
May 7, 2021 · Organon will be a global healthcare company formed through a spinoff from Merck to focus on improving the health of women throughout their lives. It will have a portfolio of more than 60 medicines and products that help address a spectrum of conditions women face.
Organon is a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established medicines across a wide array of conditions and diseases. Our...
Jun 3, 2021 · Mumbai, India, June 3 – Organon, today celebrates its launch as the only global company of its size focused on women’s health. With the mission to deliver impactful medicines and solutions, Organon will focus its efforts on building a healthier every day for every woman.
Aug 8, 2023 · Organon & Co reported better-than-expected second-quarter results on Tuesday, helped by strong demand for its women's heath products and biosimilar drugs, sending the healthcare firm's shares up...
Jun 15, 2021 · The Edge says Organon will become a major player in the women's health space (with leading contraceptive and fertility products), on top of benefiting from the highly profitable portfolio of ...
